Compare ARK Genomic Revolution ETF (ARKG) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs PAGSEG Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.8, while PAGSEG Inc trades at $9.34 (market cap $2.59B). The key difference: PAGSEG Inc pays a 11.24% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, PAGSEG Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | PAGS | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $12.00 |
52-Week Low | $23.09 | $7.75 |
Market Cap | — | $2.59B |
Enterprise Value | — | $10.22B |
Dividend Yield | — | 11.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
PAGS trades at $9.25, up 2.78% with neutral technical indicators showing support at $9 and resistance at $9. The stock presents strong value fundamentals with a P/E of 6.55 and P/B of 0.92, supported by solid profitability including 10.4% net margins and 14.52% ROE. Recent earnings showed mixed results with a Q1 2026 miss but Q4 2025 beat, while the company maintains robust cash flow generation of $7.56B from operations.
The investment case centers on deep valuation discounts and Brazil's rate-cutting cycle potential, though execution risks and competitive pressures remain. Analyst consensus is strongly bullish with 62.5% buy ratings, viewing current levels as attractive for long-term investors given the company's banking and credit expansion trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
